SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-025401
Filing Date
2018-04-18
Accepted
2018-04-18 17:05:12
Documents
2
Period of Report
2018-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1568
2 POA DOCUMENT poa.txt EX-24.3_784297 3514
  Complete submission text file 0001209191-18-025401.txt   6523
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
Saia John G. (Reporting) CIK: 0001737840 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35068 | Film No.: 18761758